II-Agent - The first open source agent that is SOTA!

II-Agent - The first open source agent that is SOTA!

The future of AI agents is here, but who really controls them? While closed-source giants such as Manus and GenSpark AI dominate the AI landscape, II-Agent is now taking center stage—and bringing a revolution with it!

This generalist is no ordinary AI assistant. II-Agent is a groundbreaking open-source framework that not only leads existing benchmarks, but is also completely transparent and auditable. Imagine an intelligent partner that supports you in every area, from complex research to precise code generation to in-depth data analysis. Powered by the robust Claude 3.7 Sonnet, II-Agent is the heart of the ambitious “Intelligent Internet” system, which aims to increase the intelligence of humanity through open models, datasets, and agent swarms.

For us as an AI community, this means freedom: we get a powerful tool whose inner workings we can understand, adapt, and improve together. It creates the essential foundation of trust for the use of AI in sensitive areas such as healthcare and education. Are you ready to help shape the infrastructure of an interoperable, accountable, and community-driven AI future? Let's make the world smarter!

Why it matters: II-Agent paves the way for trustworthy, transparent, and community-based AI development. It enables democratic participation in the design and use of autonomous systems that can transform our lives.

Prevent coupon abuse, protect your profits

KeepCart: Coupon Protection partners with D2C brands like Quince, Blueland, Vessi and more to stop/monitor coupon leaks to sites/extensions like Honey, CapitalOne, RetailMeNot, and more to boost your DTC margins

Overpaid commissions to affiliates and influencers add up fast - Get rid of the headache and revenue losses with KeepCart.

Try it 14 days free - No risk, Cancel anytime

GenSpark’s AI Sheets Turns Spreadsheets Into Conversational Assistants

GenSpark AI Sheets is redefining how we interact with data by letting users talk directly to their spreadsheets. Simply upload a file, ask a question, and the system handles everything—from data cleaning to generating detailed reports and visualizations. It’s a seamless blend of AI magic and productivity that makes complex analysis feel effortless.

Gemini 2.5 Flash is the new price-performance-ratio king.

NMN as a promising treatment for Parkinson's disease

A brand-new preprint study (May 2025) shows that nicotinamide mononucleotide (NMN), a precursor of NAD+, can positively influence the pathological cascade of alpha-synuclein in Parkinson's mouse models. This opens up new perspectives for therapies against neurodegenerative diseases by targeting cellular energy and protein aggregation. In the future, this could lead to treatments that slow down or prevent Parkinson's disease, thereby significantly improving healthspan in old age.

Epigenome in motion

A Freiburg-Oxford team reveals that DNA methylation in mammalian cells is not a static clock, but pulsates as phase-locked oscillations along the chromatin. These “turnover waves” form synchronized domains that can be specifically stopped or reset. The study provides a physical model that opens up new approaches for rhythm-based rejuvenation therapies and heralds the next generation of epigenetic intervention strategies.

First customized CRISPR cure in vivo

Doctors in Philadelphia corrected a single mutation in a baby with a rare liver defect using lipid nanoparticle CRISPR directly in the body. The procedure reduced toxic ammonia and demonstrates the potential of personalized in vivo gene correction – a preview of scalable platforms for hundreds of rare diseases.